Page last updated: 2024-09-03

y 27632 and Bone Neoplasms

y 27632 has been researched along with Bone Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiadini, V; Manara, MC; Picci, P; Pinca, RS; Scotlandi, K; Zucchini, C1
Harimaya, K; Iwamoto, Y; Matsuda, S; Matsumoto, Y; Nakatani, F; Tanaka, K1

Other Studies

2 other study(ies) available for y 27632 and Bone Neoplasms

ArticleYear
Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.
    Oncology reports, 2017, Volume: 37, Issue:3

    Topics: Amides; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Differentiation; Cell Movement; Cell Proliferation; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Pyridines; rho-Associated Kinases; Sarcoma, Ewing; Tumor Cells, Cultured

2017
Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells.
    Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:4

    Topics: Actins; Amides; Bone Neoplasms; Cell Adhesion; Cell Movement; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Extracellular Matrix; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Osteosarcoma; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-2; Tyrosine

2001